Tech Company Financing Transactions

TetraPhase Pharmaceuticals Funding Round

TetraPhase Pharmaceuticals, based in Watertown, secured $25 million in investment from Mediphase Venture Partners, F-Prime Capital and Flagship Pioneering.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

480 Arsenal St. 110
Watertown, MA 02472
USA

Phone

(617) 715-3600

Website

www.tphase.com

Email Address

[email protected]

Overview

Tetraphase Pharmaceuticals is focused on the discovery and development of new tetracycline antibiotics to treat drug resistant bacterial infections.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Guy Macdonald

        

Chief Medical Officer

Larry Tsai

        

Chief Operating Officer

Larry Edwards

        

Chief Scientific Officer

Jacques Dumas

        

VP - Finance

Christopher Watt

        

VP - General Counsel

Maria Stahl

        

Browse more venture capital transactions:

Prev: 11/27/2006: BME venture capital transaction
Next: 11/27/2006: CardioSpectra venture capital transaction

Share this article

Where The Data Comes From

We report on funding rounds that are announced publicly. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary